Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients
Public ClinicalTrials.gov record NCT02435849. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Single Arm, Multicenter Trial to Determine the Efficacy and Safety of CTL019 in Pediatric Patients With Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia
Study identification
- NCT ID
- NCT02435849
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- CTL019 Biological
Biological
Eligibility (public fields only)
- Age range
- Up to 25 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 7, 2015
- Primary completion
- Jan 20, 2020
- Completion
- Nov 16, 2022
- Last update posted
- Feb 12, 2024
2015 – 2022
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Childrens Hospital Los Angeles SC CTL019 | Los Angeles | California | 90027 | — |
| Stanford Universtiy Medical Center SC - CTL019B2205J - B2206 | Stanford | California | 94304 | — |
| Children's Healthcare of Atlanta SC CTL019 | Atlanta | Georgia | 30342 | — |
| University of Michigan . | Ann Arbor | Michigan | 48109-2800 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Children s Mercy Hospital SC - CTL019B2205J | Kansas City | Missouri | 64108 | — |
| Duke Unversity Medical Center . | Durham | North Carolina | 27705 | — |
| Oregon Health and Science University Doernbecher Children's Hosp. | Portland | Oregon | 97239-3098 | — |
| The Childrens Hospital of Philadelphia CHOP | Philadelphia | Pennsylvania | 19104 | — |
| University of Texas Southwestern Medical Center . | Dallas | Texas | 75235 | — |
| University of Utah Clinical Trials Office SC - CTL019B2205J | Salt Lake City | Utah | 84108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02435849, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 12, 2024 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02435849 live on ClinicalTrials.gov.